NCT00008268View on ClinicalTrials.gov

Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2000

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

filgrastim

DRUG

melphalan

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00008268 - Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter